Live Quote · NASDAQPTPIHealthcare· Drug Manufacturers - Specialty & Generic

Petros Pharmaceuticals, Inc.

$0.01 0.00%(+$0.00)
TickerSpark Score
59/100
Mixed
84
Valuation
60
Profitability
55
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTPI research report →

52-Week Range8% of range
Low
$0.00
Current
$0.01
High
$0.04
Company Overviewwww.petrospharma.com

About the company

Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED).

CEO
Joshua N. Silverman
IPO
2020
Employees
18
HQ
New York City, NY, US

Price Chart

-85.71% · this period
$0.04$0.02$0.01Jul 02Dec 31Jul 02
Valuation
Market Cap
$155.80K
P/E
0.00
P/S
0.00
P/B
0.13
EV/EBITDA
1.17
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
102.32%
ROIC
-237.69%
Growth & Income
Revenue
$0 · -100.00%
Net Income
$1.91M · 113.36%
EPS
$-1.56 · 53.29%
Op Income
$-4,641,350
FCF YoY
-156.30%
Performance & Tape
52W High
$0.04
52W Low
$0.00
50D MA
$0.01
200D MA
$0.01
Beta
1.87
Avg Volume
102.89K

Get TickerSpark's AI analysis on PTPI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 18, 26WEINSTEIN ROBERTother0
Jun 5, 26WALKER WAYNE REMELLother375,000
Jun 5, 26Boctor Fadyother375,000
Jun 5, 26Bernstein Bruceother1,875,000
Jun 5, 26Silverman Joshuaother4,375,000
Jan 2, 26Boctor Fadyother500,000
Jan 2, 26Silverman Joshuaother4,375,000
Jan 2, 26WALKER WAYNE REMELLother500,000
Jan 2, 26Bernstein Bruceother1,875,000
Feb 19, 25WALKER WAYNE REMELLother150,000
Coverage · PTPI

Our PTPI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PTPI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PTPI report →
Internal Compare

Similar companies

Peers in the same neighborhood.